Filing Details

Accession Number:
0001213900-15-009534
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-12-17 09:36:39
Reporting Period:
2015-12-15
Filing Date:
2015-12-17
Accepted Time:
2015-12-17 09:36:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1553643 Relmada Therapeutics Inc. RLMD Pharmaceutical Preparations (2834) 455401931
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1565832 Sergio Traversa C/O Relmada Therapeutics, Inc.
757 Third Avenue, Suite 2018
New York NY 10017
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-12-15 241 $2.92 320,593 No 4 P Direct
Common Stock Acquisiton 2015-12-15 2,759 $2.99 323,352 No 4 P Direct
Common Stock Acquisiton 2015-12-15 2,370 $2.98 325,722 No 4 P Direct
Common Stock Acquisiton 2015-12-15 5,600 $2.91 331,322 No 4 P Direct
Common Stock Acquisiton 2015-12-15 4,358 $3.00 335,680 No 4 P Direct
Common Stock Acquisiton 2015-12-15 1,600 $3.40 337,280 No 4 P Direct
Common Stock Acquisiton 2015-12-15 42 $3.39 337,322 No 4 P Direct
Common Stock Acquisiton 2015-12-15 200 $3.34 337,522 No 4 P Direct
Common Stock Acquisiton 2015-12-15 1,800 $3.42 339,322 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct